PT  - JOURNAL ARTICLE
AU  - Lai, Alessia
AU  - Bergna, Annalisa
AU  - Acciarri, Carla
AU  - Galli, Massimo
AU  - Zehender, Gianguglielmo
TI  - Early Phylogenetic Estimate Of The Effective Reproduction Number Of 2019-nCoV
AID  - 10.1101/2020.02.19.20024851
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.02.19.20024851
4099  - http://medrxiv.org/content/early/2020/02/23/2020.02.19.20024851.short
4100  - http://medrxiv.org/content/early/2020/02/23/2020.02.19.20024851.full
AB  - To reconstruct the evolutionary dynamics of the 2019 novel coronavirus, 52 2019-nCOV genomes available on 04 February 2020 at GISAID were analysed.The two models used to estimate the reproduction number (coalescent-based exponential growth and a birth-death skyline method) indicated an estimated mean evolutionary rate of 7.8 × 10−4 subs/site/year (range 1.1×10−4–15×10−4).The estimated R value was 2.6 (range 2.1-5.1), and increased from 0.8 to 2.4 in December 2019. The estimated mean doubling time of the epidemic was between 3.6 and 4.1 days.This study proves the usefulness of phylogeny in supporting the surveillance of emerging new infections even as the epidemic is growing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for this workAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll sequences used are publicly available at GISAID(Global Initiative on Sharing All Influenza Data)website https://www.gisaid.org/